Vascular endothelial growth factor expression in human neuroblastoma: Up-regulation by hypoxia

International Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 113-117

  Rössler, Jochen ^a   Breit, Stephen ^a   Havers, Werner ^a   Schweigerer, Lothar ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOBLOTTING; MALIGNANT TRANSFORMATION; MICROVASCULATURE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VASCULARIZATION;

CELL DIVISION; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; PROTEIN ISOFORMS; TUMOR CELLS, CULTURED; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033020069     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990331)81:1<113::AID-IJC19>3.0.CO;2-L     Document Type: Article

References (36)

1. BERTHOLD, F., Overview, biology of neuroblastoma. In: C. Pochedly (ed.), Neuroblastoma, tumor biology and therapy, pp. 1-27, CRC Press, Boca Raton, FL (1990).
2. BORGSTRÖM, P., HILLAN, K.J., SRIRAMARAO, P. and FERRARA, N., Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody. Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56, 4032-4039 (1996).
3. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
4. FERRARA, N. and DAVIS-SMYTH, T., The biology of vascular endothelial growth factor. Endocrinol. Rev., 18, 4-25 (1997).
5. FERRARI, G. and SCAGLIOTTI, G.V., Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients. Europ. J. Cancer, 32A, 2368-2369 (1996).
6. FOTSIS, T., PEPPER, M.S., AKTAS, E., BREIT, S., RASKU, S., ADLERCREUTZ, H., WÄHÄLÄ, K., MONTESANO, R. and SCHWEIGERER, L., Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res., 57, 2916-2921 (1997).
7. FOTSIS, T., ZHANG, Y., PEPPER, M.S., ADLERCREUTZ, H., MONTESANO, R., NAWROTH, P.P. and SCHWEIGERER, L., The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature (Lond.), 368, 237-239 (1994).
8. FOX, S.B., Tumor angiogenesis and prognosis. Histopathology, 30, 294-301 (1997).
9. GASPARINI, G. and 12 OTHERS, Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. nat. Cancer Inst., 89, 139-147 (1997).
10. HANAHAN, D. and FOLKMAN, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364 (1996).
11. JAIN, R.K., Determinants of tumor blood flow, a review. Cancer Res., 48, 2641-2658 (1988).
12. LI, V.W., FOLKERTH, R.D., WATANABE, H., YU, C., RUPNICK, M., BARNES, P., SCOTT, R.M., BLACK, P.M., SALLAN, S.E. and FOLKMAN, J., Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet, 344, 82-86 (1994).
13. LUTZ, W., STÖHR, M., SCHÜRMANN, J., WENZEL, A., LÖHR, A. and SCHWAB, M. Conditional expression of N-myc in human neuroblastoma cells increases expression of α-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene, 13, 803-812 (1996).
14. MAEDA, K., CHUNG, Y.S., OGAWA, Y., TAKATSUKA, S., KANG, S.M., OGAWA, M., SAWADA, T. and SOWA, M., Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer, 77, 858-863 (1996).
15. MEITAR, D., CRAWFORD, S.E., RADEMAKER, A.W. and COHN, S.L., Tumor angiogenesis correlates with metastatic disease. N-myc amplification, and poor outcome in human neuroblastoma. J. clin. Oncol., 14, 405-414 (1996).
16. MU, J., ABE, Y., TSUTSUI, T., YAMAMOTO, N., TAI, X.G., NIWA, O., TSUJIMURA, T. SATO, B., TERANO, H., FUJIWARA, H. and HAMAOKA, T., Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. Jpn. J. Cancer Res., 87, 963-971 (1996).
17. MUKHOPADHYAY, D., TSIOKAS, L. and SUKHATME, V.P., Wild-type p53 and v-src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res., 55, 6161-6165 (1995).
18. NAGABUCHI, E., VANDERKOLK, W.E., UNE, Y. and ZIEGLER, M.M., TNP-470 antiangiogenic therapy for advanced murine neuroblastoma. J. pediatr. Surg., 32, 287-293 (1997).
19. PEREZ-ATAYDE, A.R., SALLAN, S.E., TEDROW, U., CONNORS, S., ALLRED, E. and FOLKMAN, J., Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Amer. J. Pathol., 150, 815-821 (1997).
20. PLATE, K.H., BREIER, G., WEICH, H., MENNEL, H.D. and RISAU, W., Vascular endothelial growth factor and glioma angiogenesis, coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer, 59, 520-529 (1994).
21. RAK, J., FILMUS, J., FINKENZELLER, G., GRUGEL, S., MARMÉ, D. and KERBEL, R.S., Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev., 14, 263-277 (1995).
22. RALEIGH, J.A., CALKINS-ADAMS, D.P., RINKER, L.H., BALLENGER, C.A., WEISSLER, M.C., FOWLER, W.C., JR., NOVOTNY, D.B. and VARIA, M.A., Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res., 58, 3765-3768 (1998).
23. RELF, M., LEJEUNE, S., SCOTT, P.A.E., FOX, S., SMITH, K., LEEK, R., MOGHADDAM, A., WHITEHOUSE, R., BICKNELL, R. and HARRIS, A.L., Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res., 57, 963-969 (1997).
24. ROSS, R.A., SPENGLER, B.A. and BIEDLER, J.L., Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. nat. Cancer Inst. 71, 741-747 (1983).
25. SCHWAB, M., Molecular cytogenetics of human neuroblastoma. Biochim. Biophys. Acta Rev. (Cancer), 1114, 43-50 (1992).
26. SCHWEIGERER, L., Antiangiogenesis as a novel therapeutic concept in pediatric oncology. J. mol. Med., 73, 497-508 (1995).
27. SCHWEIGERER, L., BREIT, S., WENZEL, A., TSUNAMOTO, K., LUDWIG, R. and SCHWAB, M., Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells. Evidence for induction of autocrine growth activity. Cancer Res., 50, 4411-4416 (1990).
28. SCHWEIGERER, L., NEUFELD, G., FRIEDMAN, J., ABRAHAM, J.A., FIDDES, J.C. and GOSPODAROWICZ, D., Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (Lond.), 325, 257-259 (1987).
29. SHWEIKI, D., ITIN, A., SOFFER, D. and KESHET, E., Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359, 843-845 (1992).
30. SONE, H., KAWAKAMI, Y., OKUDA, Y., KONDO, S., HANATANI, M., SUZUKI, H. and YAMASHITA, K., Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem. biophys. Res. Comm., 221, 193-198 (1996).
31. TAKANO, S., YOSHII, Y., KONDO, S., SUZUKI, H., MARUNO, T., SHIRAI, S. and NOSE, T., Concentration of vascular endothelial erowth factor in the serum and tumor tissue of brain tumor patients. Cancer Res., 56, 2185-2190 (1996).
32. TANIGAWA, N., AMAYA, H., MATSUMURA, M. and SHIMOMATSUYA, T., Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J. clin. Oncol., 15, 826-832 (1997).
33. TRICHE, T.J., ASKIN, F.B. and KISSANE, J.M., Neuroblastoma, Ewing's sarcoma, and the differential diagnosis of small-, round-, blue-cell tumors. In: M. Finegold (ed.), Pathology of neoplasia in children and adults, pp. 145-195, Philadelphia, W.B. Saunders (1986).
34. VOLM, M., KOOMÄGI, R., MATTERN, J. and STAMMLER, G., Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res., 17, 99-103 (1997).
35. WASSBERG, E., PÁHLMAN, S., WESTLIN, J.E. and CHRISTOFFERSON, R., The angiogenesis inhibitor TNP-470 reduces the growth rate of human neuroblastoma in nude rats. Pediatr. Res., 41, 327-333 (1997).
36. YUAN, F., CHEN, Y., DELLIAN, M., SAFABAKHSH, N., FERRARA, N. and JAIN, R.K., Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor vascular permeability factor antibody. Proc. nat. Acad. Sci. (Wash.), 93, 14765-14770 (1996).